A Phase II Study of Combination Chemotherapy using TS-1 and Cisplatin with Concurrent Thoracic Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer
Phase 2
- Conditions
- ocally Advanced Non-Small Cell Lung Cancer
- Registration Number
- JPRN-UMIN000001370
- Lead Sponsor
- West Japan Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
1.with Superior vena cava syndrome 2.with sever allergy 3.on going other studies or treating with uncomfortable drugs to TS-1 and cisplatin 4.contra hilar lymph nod swelling, pleural or cardiac effusion dew to cancer, lymphangitis carcinomatoses, T3N1M0 5.with sever infection, bleeding, cardiac diseases. 6.with continues diarrhea 7.ileus or sub-ireus 8.with interstitial pneumonia, sever COPD 9.Presence of other active malignancy 10.un-controlled DM 11.Uncontrolled psychiatric disease. 12.pregnancy or lactating patients 13.Others
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method